Generation and maintenance of hybridomas

J. F. Albright, Matthew D. Scharff

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The realization of the therapeutic potential of monoclonal antibodies will depend on the efficient generation and maintenance of hybridomas. At a recent workshop on the Stability and Viability of Antibody-Producing Cell Lines it was clear that there are still large gaps in the knowledge needed to achieve that aim.

Original languageEnglish (US)
Pages (from-to)257-258
Number of pages2
JournalImmunology Today
Volume8
Issue number9
StatePublished - 1987
Externally publishedYes

Fingerprint

Antibody-Producing Cells
Hybridomas
Monoclonal Antibodies
Maintenance
Education
Cell Line
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Generation and maintenance of hybridomas. / Albright, J. F.; Scharff, Matthew D.

In: Immunology Today, Vol. 8, No. 9, 1987, p. 257-258.

Research output: Contribution to journalArticle

Albright, JF & Scharff, MD 1987, 'Generation and maintenance of hybridomas', Immunology Today, vol. 8, no. 9, pp. 257-258.
Albright, J. F. ; Scharff, Matthew D. / Generation and maintenance of hybridomas. In: Immunology Today. 1987 ; Vol. 8, No. 9. pp. 257-258.
@article{4230a36d5038442e927bc924df280330,
title = "Generation and maintenance of hybridomas",
abstract = "The realization of the therapeutic potential of monoclonal antibodies will depend on the efficient generation and maintenance of hybridomas. At a recent workshop on the Stability and Viability of Antibody-Producing Cell Lines it was clear that there are still large gaps in the knowledge needed to achieve that aim.",
author = "Albright, {J. F.} and Scharff, {Matthew D.}",
year = "1987",
language = "English (US)",
volume = "8",
pages = "257--258",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Generation and maintenance of hybridomas

AU - Albright, J. F.

AU - Scharff, Matthew D.

PY - 1987

Y1 - 1987

N2 - The realization of the therapeutic potential of monoclonal antibodies will depend on the efficient generation and maintenance of hybridomas. At a recent workshop on the Stability and Viability of Antibody-Producing Cell Lines it was clear that there are still large gaps in the knowledge needed to achieve that aim.

AB - The realization of the therapeutic potential of monoclonal antibodies will depend on the efficient generation and maintenance of hybridomas. At a recent workshop on the Stability and Viability of Antibody-Producing Cell Lines it was clear that there are still large gaps in the knowledge needed to achieve that aim.

UR - http://www.scopus.com/inward/record.url?scp=33749202338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749202338&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 257

EP - 258

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 9

ER -